| fluidotherapy |
201 |
| grip strength |
201 |
| hand functions |
201 |
| hand osteoarthritis |
201 |
| paraffin |
201 |
| chinese mainland patients |
244 |
| female |
244, 252 |
| rheumatoid arthritis |
244, 192, 227 |
| sexual dysfunction |
244 |
| autoinflammatory diseases |
159 |
| depression |
159 |
| fatigue |
159 |
| hereditary |
159 |
| life quality |
159 |
| apoptosis |
185 |
| behçet’s disease |
185, 258 |
| methylation |
185 |
| survivin |
185 |
| fall risk |
167 |
| lung involvement |
167 |
| muscle strength |
167 |
| postural balance |
167 |
| systemic sclerosis |
167, 176 |
| exercise |
176 |
| microstomia |
176 |
| oral aperture |
176 |
| rehabilitation |
176 |
| estrogen receptors |
192 |
| histopathological findings |
192 |
| osteoarthritis |
192, 296 |
| progesterone receptors |
192 |
| ankle-brachial index |
210 |
| atherosclerosis |
210, 287 |
| cardiovascular disease |
210 |
| peripheral artery disease |
210 |
| psoriatic arthritis |
210 |
| spondyloarthropathy |
210 |
| colchicine-resistant familial mediterranean fever |
219 |
| familial mediterranean fever |
219 |
| multiple sclerosis |
219 |
| ocrelizumab |
219 |
| ankylosing spondylitis |
227 |
| insulin-like growth factor 1 receptor |
227 |
| rs2229765 |
227 |
| single nucleotide polymorphism |
227 |
| acute rheumatic fever |
233 |
| child |
233 |
| pentraxin 3 |
233 |
| fibromyalgia |
252, 274 |
| frequency |
252 |
| quality of life |
252, 280 |
| rosacea |
252 |
| carotid intima-media thickness |
258 |
| ultrasound |
258 |
| vascular involvement |
258 |
| venous thrombosis |
258 |
| foot posture |
267 |
| hypermobility |
267 |
| knee osteoarthritis |
267 |
| disease activity |
274 |
| health literacy |
274 |
| nottingham health profile |
280 |
| short form-12 |
280 |
| validation |
280 |
| clinical parameters |
287 |
| genetic variance |
287 |
| systemic lupus erythematosus |
287 |
| systemic lupus erythematosus disease activity index |
287 |
| microbiota |
296 |
| pain |
296 |
| probiotics |
296 |
